Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)
N/A
Multiple Sclerosis (MS) is not only an 'inflammatory' demyelinating disease...
Status
Completed
Location
Dep. Neurology, Hospital of the University of Basel
Start Date
2012-09
Trial ID
NCT01765361
Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis
N/A
This retrospective multicenter observational study aims to develop and exte...
Status
Enrolling By Invitation
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2025-11-01
Trial ID
NCT07373951
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS
N/A
The advent of immunotherapy (immune checkpoint inhibitors \[ICI\]) has been...